EnglishVERGONI, Anna Valeria
Risultati 1 - 20 di 54 (tempo di esecuzione: 0.0 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 | 2007 | Tosi, Giovanni; Costantino, Luca; Rivasi, Francesco; Ruozi, Barbara; Leo, Eliana Grazia; Vergoni, Anna Valeria; Tacchi, Raffaella; Bertolini, Alfio; Vandelli, Maria Angela; Forni, Flavio |
| 2 | Surface decorated nanoparticles as drug delivery agents to the brain | 2009 | Badiali, Luca; Vergoni, Anna Valeria; Tosi, Giovanni; Ruozi, Barbara; Costantino, Luca; Bertolini, Alfio; Vandelli, Maria Angela; Forni, Flavio |
| 3 | Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain | 1997 | Sandrini, Maurizio; Vitale, Giovanni; Vergoni, Anna Valeria; Ottani, Alessandra; Bertolini, Alfio |
| 4 | Sistemi anti-analgesici endogeni | 1994 | Bertolini, Alfio; Poggioli, Rosanna; Bernardi, Mara; Genedani, Susanna; Guarini, Salvatore; Bazzani, Carla; Arletti, Rossana; Benelli, Augusta; Bertolini, E; Balugani, A; Vergoni, Anna Valeria |
| 5 | Similarities and differences between chronic migraine and episodic migraine | 2007 | Ferrari, Anna; S., Leone; Vergoni, Anna Valeria; Bertolini, Alfio; G., Sances; C. P. R., Coccia; Ottani, Alessandra; Pinetti, Diego; Sternieri, Emilio |
| 6 | Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution | 2010 | Tosi, Giovanni; Vergoni, Anna Valeria; Ruozi, Barbara; Bondioli, Lucia; Badiali, Luca; Rivasi, Francesco; Costantino, Luca; Forni, Flavio; Vandelli, Maria Angela |
| 7 | Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormons involved in food intake and metabolism: insulin and melanocortins | 2008 | Matias, I; Vergoni, Anna Valeria; Petrosino, S; Ottani, Alessandra; Pocai, A; Bertolini, Alfio; DI MARZO, V. |
| 8 | Receptor heteromerization in adenosine A2A receptor signaling | 2003 | Fuxe, K.; Agnati, Luigi Francesco; Jacobsen, K.; Hillion, J.; Canals, M.; Torvinen, M.; Tinnerstaines, B.; Staines, W.; Rosin, D.; Terasmaa, A.; Popoli, P.; Leo, Giuseppina; Vergoni, Anna Valeria; Lluis, C.; Ciruela, F.; Franco, R.; Ferre', S. |
| 9 | Putrescine has antiarrhythmic effects in rat models of arrhythmia. | 1990 | Tagliavini, S.; Bazzani, Carla; Genedani, Susanna; Vergoni, Anna Valeria; Bertolini, Alfio |
| 10 | Polymeric nanoparticles for CNS drug delivery: strategies and perspectives | 2010 | Tosi, Giovanni; Bondioli, Lucia; Badiali, Luca; Ruozi, Barbara; Vergoni, Anna Valeria; Rivasi, Francesco; Vandelli, Maria Angela; Forni, Flavio |
| 11 | Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept | 2010 | Tosi, Giovanni; Fano, Rita Adriana; Badiali, Luca; Bondioli, Lucia; Ruozi, Barbara; Vergoni, Anna Valeria; Rivasi, Francesco; Benassi, Rois; Vandelli, Maria Angela; Forni, Flavio |
| 12 | Peptide-derivatized nanoparticles as carriers of drugs into the central nervous system | 2007 | Tacchi, Raffaella; Vergoni, Anna Valeria; Tosi, Giovanni; Costantino, Luca; Rivasi, Francesco; Bertolini, Alfio; Ruozi, Barbara; Forni, Flavio; Vandelli, Maria Angela |
| 13 | Peptide-decorated nanoparticles as carriers for drug delivery to CNS | 2008 | Costantino, Luca; Bondioli, Lucia; Tosi, Giovanni; Vergoni, Anna Valeria; Tacchi, Raffaella; Bertolini, Alfio; Vandelli, Maria Angela; Forni, Flavio |
| 14 | Oral delivery of insulin loaded into polymeric nanoparticles in rats. | 2011 | Tosi, Giovanni; Vergoni, Anna Valeria; Ruozi, Barbara; Bondioli, Lucia; Forni, Flavio; Vandelli, Maria Angela; Tacchi, Raffaella; Ferrari, Anna; Spaccapelo, Luca; Bertolini, Alfio |
| 15 | NPY-induced inhibition of male copulatory acivity is a direct behavioural effect | 1990 | Poggioli, Rosanna; Vergoni, Anna Valeria; D., Marrama; Giuliani, Daniela; Bertolini, Alfio |
| 16 | New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes | 2009 | Tosi, Giovanni; Ruozi, Barbara; Vergoni, Anna Valeria; Bondioli, Lucia; Badiali, Luca; Belletti, Daniela; Forni, Flavio; Vandelli, Maria Angela |
| 17 | Neuroprotective effect of L-DOPA co-administered with the adenosine A(2A) receptor agonist CGS 21680 in an animal model of Parkinson's disease | 2004 | Agnati, Luigi Francesco; Leo, Giuseppina; Vergoni, Anna Valeria; E., Martinez; J., Hockemeyer; C., Lluis; R., Franco; K., Fuxe; S., Ferre |
| 18 | Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat | 2000 | Vergoni, Anna Valeria; Ottani, Alessandra; Botticelli, A. R.; Zaffe, Davide; Guano, L.; Loche, A.; Genedani, Susanna; Gessa, G. L.; Bertolini, Alfio |
| 19 | Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing | 2010 | Tosi, Giovanni; Fano, Rita Adriana; Badiali, Luca; Bondioli, Lucia; Ruozi, Barbara; Vergoni, Anna Valeria; Rivasi, Francesco; Benassi, Rois; Vandelli, Maria Angela; Forni, Flavio |
| 20 | Nanoparticles for brain delivery of drugs: in vivo experiments and mechanism of BBB crossing | 2011 | Tosi, Giovanni; Fano, Rita Adriana; Badiali, Luca; Bondioli, Lucia; Ruozi, Barbara; Vergoni, Anna Valeria; Rivasi, Francesco; Benassi, Rois; Vandelli, Maria Angela; Forni, Flavio |
Nome completo:
VERGONI, Anna Valeria
struttura:
Dipartimento di Scienze Biomediche, Metaboliche e Neuroscienze
settore SSD:
Settore BIO/14 - Farmacologia
Varianti:
A. M. Vergoni
Copyright © 2019